• Cabazitaxel (XRP6258): Practical Workflow Guide

  2026-09-22

  Cabazitaxel (XRP6258, SKU B2157) provides a defined starting point for antiproliferative assays involving taxane-resistant and P-glycoprotein-expressing cancer models. It is intended for validated DMSO- or ethanol-based workflows, not water-based preparation or prolonged storage of solutions.

• ICAA Disrupts HBV via HO-1–ROS Modulation

  2026-09-22

  The reference study shows that isochlorogenic acid A (ICAA) suppresses hepatitis B virus replication at multiple stages, including viral transcription, cccDNA-associated processes, capsid formation, and envelopment. Its findings connect these effects with HO-1 upregulation and altered intracellular reactive oxygen species, providing a mechanistic framework for studying redox control of HBV morphogenesis rather than treating ICAA as a single-target antiviral.

• SB-3CT: A Gelatinase Inhibitor Workflow Guide

  2026-09-21

  SB-3CT is a mechanism-based gelatinase inhibitor for separating MMP-2 and MMP-9 contributions to extracellular-matrix remodeling. This guide translates its biochemical selectivity into workflows for perineuronal-net studies, tumor metastasis research, angiogenesis inhibition, and neuroprotection in cerebral ischemia while emphasizing controls and interpretation limits.

• Targeted SPP1 Inhibition Reprograms Tumor Myeloid Cells

  2026-09-21

  The reference study developed a macrophage phenotypic screen and a TAM-avid CANDI nanoconstruct to identify and deliver small-molecule modulators that suppress SPP1. Its lead compound, CANDI460, reduced SPP1 expression in vitro and in vivo and produced tumor remissions in multiple murine models, supporting tumor-associated myeloid-cell reprogramming as a therapeutic strategy.

• Anlotinib hydrochloride: Assay Workflows for Angiogenesis

  2026-09-20

  Anlotinib hydrochloride enables mechanism-focused studies of VEGFR2, PDGFRβ, and FGFR1 signaling across migration, tube formation, and phosphorylation assays. This workflow-oriented guide shows how to separate genuine anti-angiogenic activity from cytotoxicity and how to interpret cell-based findings in the context of translational cancer research.

• Kupffer Cell Plasticity in Liver Metastatic Niches

  2026-09-19

  This study shows that liver metastasis-associated macrophages are sustained not only by recruited monocyte-derived macrophages but also by local macrophage proliferation and infiltration of reprogrammed Kupffer cells. Its lineage-tracing, proliferation-recording, CITE-seq, and epigenetic analyses reveal why blocking monocyte input alone may be insufficient and provide a mechanistic framework for interpreting macrophage-targeted interventions.

• Chemistry of Silybin: Structure, Synthesis, and Uses

  2026-09-18

  The reference review establishes silybin as a chemically defined flavonolignan rather than treating Silymarin as a single compound. Its most important advances are the assignment of the absolute configurations of silybin A and silybin B, the development of separation strategies, and the systematic analysis of synthetic, enzymatic, and antioxidant chemistry.

• IL-2, Human Recombinant: Assay Workflow Guide

  2026-09-18

  Build a controlled IL-2 dose–response workflow for immune-cell expansion, recovery, and functional testing while avoiding confounding cytokine effects in granule assays. The approach translates concentration-threshold and multivalency concepts from a neuronal phase-separation study into practical experimental controls without claiming that IL-2 reproduces the FUS–SMN mechanism.

• Relative vs Fractional Viability in Cancer

  2026-09-17

  Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent components of an in vitro drug response. This framework supports better assay selection, time-point design, and interpretation of cytotoxicity results.

• Chlorambucil: Designing Better Cancer Assays

  2026-09-17

  Chlorambucil is a nitrogen mustard alkylating agent whose DNA damage can produce both growth arrest and cell death. This guide translates dissertation-level assay insights into a practical framework for interpreting chlorambucil responses across cancer and primary-cell models.

• MiR-24-3p, Sp1/PI3K, and Doxorubicin Heart Failure

  2026-09-16

  The reference study identifies miR-24-3p as a regulator of doxorubicin-induced cardiac injury and links its effects to the Sp1/PI3K signaling pathway. Using rat and H9c2 cell models, the authors show that miR-24-3p silencing reduces apoptosis and oxidative stress, providing a mechanistic framework for studying transcriptional control in heart failure.

• Direct Mouse Genotyping Kit Plus for EP4 Models

  2026-09-16

  Accelerate genotype confirmation in EP4 and ApoE mouse colonies with a direct tissue-to-PCR workflow that minimizes purification steps. The kit is especially useful for transgene detection, conditional allele screening, and rapid quality control before mechanistic atherosclerosis studies.

• Masitinib (AB1010) Workflow Guide

  2026-09-15

  Masitinib (AB1010; SKU A2942) provides a DMSO-compatible research tool for focused KIT, PDGFRα, and PDGFRβ inhibition in cancer biology, mast cell, and inflammatory workflows. It is suitable for biochemical and cellular assays but should not be used as a substitute for clinical dosing evidence, broad-spectrum kinase inhibition, or aqueous- or ethanol-based protocols.

• LDH Cytotoxicity Assay Kit: Practical QC Guide

  2026-09-15

  The LDH Cytotoxicity Assay Kit (SKU K2228) provides a non-radioactive colorimetric method for cell cytotoxicity measurement and cell damage quantification through LDH released into culture medium. It is suited to comparative in vitro studies, but LDH release alone should not identify apoptosis or another death pathway, and the assay should not be used as a standalone in vivo or clinical test.

• EdU Flow Cytometry Assay Kits (Cy5): S-Phase

  2026-09-14

  EdU Flow Cytometry Assay Kits (Cy5) measure DNA synthesis during S phase through copper-catalyzed azide-alkyne cycloaddition (CuAAC). The K1078 workflow provides a denaturation-free, Cy5-based readout for flow cytometry cell proliferation assays and can support validation of cell-cycle changes reported in diabetic foot ulcer models.

8083 records 1/539 page Next 12345 下5页 Last page